Treatment
- IV: For cystic fibrosis patients presenting with acute exacerbation of multidrug-resistant infections where tobramycin is insufficient or not tolerated
- Inhalation: For chronic suppressive therapy in cystic fibrosis patients with multidrug-resistant infections where tobramycin is insufficient or not tolerated
- Infectious Diseases consult required for other indications
